Breaking News, Promotions & Moves

Antag Therapeutics Names Joerg Moeller as CEO

Moeller has extensive experience in bringing first-in-class and best-in-class therapies to market across a wide range of therapeutic areas.

Author Image

By: Charlie Sternberg

Associate Editor

Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has appointed Joerg Moeller, MD, PhD, as Chief Executive Officer, effective immediately. Moeller succeeds Antag’s Co-Founder and former CEO, Dr. Alexander Sparre-Ulrich, who played a pivotal role in reaching clinical inflection points and establishing Antag as a leader in GIP receptor antagonism. Sparre-Ulrich will move into the position of Chief Operating Officer and will continue to support the co...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters